Get More Information on Alopecia Treatment Market - Request Sample Report
The Alopecia Treatment Market Size was valued at USD 8.80 Billion in 2023, and is expected to reach USD 20.70 Billion by 2032, and grow at a CAGR of 10.48%.
The increasing prevalence of alopecia across the globe is one of the major factors boosting the growth of the alopecia treatment market. Increasing consumption of junk food, a sedentary lifestyle, and rising stress levels are the major reasons for the high rate of hair fall and hair damage. The disease is more prevalent in males. Increasing preference for aesthetic beauty is one of the reasons leading the population towards getting treatment for alopecia and boosting the alopecia treatment market. The International Society of Hair Restoration Surgery (ISHRS) reports that 35 million males in the U.S. are affected by hair loss each year. The increasing prevalence is expected to drive more individuals toward hair restoration treatment options. The launch of new products is also expected to attract the patient population to this market and boost the growth in this market throughout the forecast period. ISHRS also reports that the increase in the prevalence of the disease has helped improve overall hair restoration procedures by more than 60% since the year 2015. Hence, the rising prevalence of alopecia and the increasing patient pool are some of the factors that are expected to boost growth in this market.
MARKET DYNAMICS:
Key Drivers:
Restraints:
Opportunity:
KEY MARKET SEGMENTATION:
By Route of Administration
The topical solution comprised 46% of the market in 2023, driven by increasing demand for alopecia treatment. These solutions come in various forms and are preferred for their availability and ease of use. The oral drugs segment dominated the market in 2023 and is expected to continue due to increased authorization for their use in alopecia treatment.
By Gender Type
Androgenic alopecia or hair loss is primarily present in males, which is why the male segment dominated the market with 75%. The increasing prevalence of androgenic alopecia is the most significant factor driving the growth of the segment. Moreover, the male patient population is rapidly growing across the globe, which is also contributing to the high share of this segment.
The female segment, in contrast, is expected to experience steady growth during the forecast period due to the skin infection-prone- the surface of the scalp, which results from the use of serums or lotions on hair. Both men and women are on the same pace of usage of alopecia treatments.
Need any customization research on Alopecia Treatment Market- Enquiry Now
By Age Group
The 18-34-year-old age group holds the largest share of the alopecia treatment market, accounting for 31% in 2023. This is due to the increasing number of young adults seeking alopecia treatment within this age Meanwhile range. Meanwhile, the 35–49-year-old segment dominated the market with 33% in 2023. This is attributed to the growing prevalence of alopecia among middle-aged individuals. Factors such as diabetes, hypertension, stress, a sedentary lifestyle, and other health conditions make people in this age group more susceptible to severe hair loss. These health conditions are among the major factors contributing to the development of alopecia in middle-aged individuals.
REGIONAL ANALYSIS:
North America dominated the regional shares in alopecia treatment in 2023 with a share of 40%. The key contributors are the high prevalence of the disease, increased awareness among consumers, proactive measures taken by the government, improvements in the healthcare infrastructure, and advancements in technology. Also, the rising adoption of laser-based therapy for treatment is one of the other factors leading to an increased treatment rate in North America. Also, the presence of several governments and a non-profit organization such as the National Alopecia Areata Foundation, Canadian Alopecia Areata Foundation, etc. that provide the guidelines and spread awareness among the people is expected to augment the market.
KEY PLAYERS:
The key market players are Sun Pharmaceutical Industries Ltd., Follicum AB, GlaxoSmithKline plc., Daiichi Sankyo, Fagron, Concert Pharmaceuticals Inc., Johnson & Johnson, bAclaris Therapeutics, Inc., Cipla Inc., Merck & Co., Inc. & other players.
RECENT DEVELOPMENTS
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | US$ 8.80 Billion |
| Market Size by 2032 | US$ 20.70 Billion |
| CAGR | CAGR of 10.48% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | •By Route of Administration (Topical, Injectable, Oral) •By Gender Type (Male, Female) •By Age Group (Below 18 years, 18 - 34 Years, 35 - 49 Years, Above 50 Years) •By End User (Hospitals and Physicians offices, Dermatology Clinics & Others) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Sun Pharmaceutical Industries Ltd., Follicum AB, GlaxoSmithKline plc., Daiichi Sankyo, Fagron, Concert Pharmaceuticals Inc., Johnson & Johnson, bAclaris Therapeutics, Inc., Cipla Inc., Merck & Co., Inc. and other players |
| Key Drivers | •Growing Prevalence of Alopecia Drives Demand for Alopecia Treatment Market. •Growing Demand for Natural and Organic Hair Loss Products is Boosting the Demand For Alopecia Treatment Market. |
| RESTRAINTS | •The High Cost of Advanced Treatment Options is Hindering the Growth of Alopecia Treatment Market. •Side Effects and Limited Effectiveness of Certain Treatment Options Restraining Alopecia Treatment Market Growth. |
Ans. The compound annual growth rate for Alopecia Treatment Market for the forecast period is 10.48%.
Ans. The Alopecia Treatment Market was valued at USD 8.80 Billion in 2023.
Ans. During the projected period, the topical category is likely to be the market leader.
Ans. The Alopecia Treatment Market will be valued at USD 20.70 Billion in 2032.
Ans. Acclaris Therapeutics, Inc. is a market leader in the global market.
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Prescription Trends, (2023), by Region
5.3 Device Volume, by Region (2020-2032)
5.4 Healthcare Spending, by Region, (Government, Commercial, Private, Out-of-Pocket), 2023
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and supply chain strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Alopecia Treatment Market Segmentation, by Route of Administration
7.1 Chapter Overview
7.2 Topical
7.2.1 Topical Market Trends Analysis (2020-2032)
7.2.2 Topical Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Injectable
7.3.1 Injectable Market Trends Analysis (2020-2032)
7.3.2 Injectable Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Oral
7.4.1 Oral Market Trends Analysis (2020-2032)
7.4.2 Oral Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Alopecia Treatment Market Segmentation, by Gender Type
8.1 Chapter Overview
8.2 Male
8.2.1 Male Market Trends Analysis (2020-2032)
8.2.2 Male Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Female
8.3.1 Female Market Trends Analysis (2020-2032)
8.3.2 Female Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Alopecia Treatment Market Segmentation, by Age Group
9.1 Chapter Overview
9.2 Below 18 years
9.2.1 Below 18 years Market Trends Analysis (2020-2032)
9.2.2 Below 18 years Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 18 - 34 Years
9.3.1 18 - 34 Years Market Trends Analysis (2020-2032)
9.3.2 18 - 34 Years Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 35 - 49 Years
9.4.1 35 - 49 Years Market Trends Analysis (2020-2032)
9.4.2 35 - 49 Years Market Size Estimates and Forecasts to 2032 (USD Billion)
9.5 Above 50 Years
9.5.1 Above 50 Years Market Trends Analysis (2020-2032)
9.5.2 Above 50 Years Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Alopecia Treatment Market Segmentation, by End User
10.1 Chapter Overview
10.2 Hospitals and Physicians offices
10.2.1 Hospitals and Physicians offices Market Trends Analysis (2020-2032)
10.2.2 Hospitals and Physicians offices Market Size Estimates and Forecasts to 2032 (USD Billion)
10.3 Dermatology Clinics
10.3.1 Dermatology Clinics Market Trends Analysis (2020-2032)
10.3.2 Dermatology Clinics Market Size Estimates and Forecasts to 2032 (USD Billion)
10.4 Others
10.4.1 Others Market Trends Analysis (2020-2032)
10.4.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
11. Regional Analysis
11.1 Chapter Overview
11.2 North America
11.2.1 Trends Analysis
11.2.2 North America Alopecia Treatment Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
11.2.3 North America Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.2.4 North America Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.2.5 North America Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.2.6 North America Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.2.7 USA
11.2.7.1 USA Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.2.7.2 USA Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.2.7.3 USA Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.2.7.4 USA Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.2.8 Canada
11.2.8.1 Canada Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.2.8.2 Canada Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.2.8.3 Canada Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.2.8.4 Canada Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.2.9 Mexico
11.2.9.1 Mexico Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.2.9.2 Mexico Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.2.9.3 Mexico Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.2.9.4 Mexico Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.3 Europe
11.3.1 Eastern Europe
11.3.1.1 Trends Analysis
11.3.1.2 Eastern Europe Alopecia Treatment Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
11.3.1.3 Eastern Europe Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.3.1.4 Eastern Europe Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.3.1.5 Eastern Europe Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.3.1.6 Eastern Europe Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.3.1.7 Poland
11.3.1.7.1 Poland Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.3.1.7.2 Poland Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.3.1.7.3 Poland Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.3.1.7.4 Poland Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.3.1.8 Romania
11.3.1.8.1 Romania Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.3.1.8.2 Romania Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.3.1.8.3 Romania Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.3.1.8.4 Romania Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.3.1.9 Hungary
11.3.1.9.1 Hungary Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.3.1.9.2 Hungary Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.3.1.9.3 Hungary Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.3.1.9.4 Hungary Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.3.1.10 Turkey
11.3.1.10.1 Turkey Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.3.1.10.2 Turkey Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.3.1.10.3 Turkey Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.3.1.10.4 Turkey Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.3.1.11 Rest of Eastern Europe
11.3.1.11.1 Rest of Eastern Europe Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.3.1.11.2 Rest of Eastern Europe Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.3.1.11.3 Rest of Eastern Europe Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.3.1.11.4 Rest of Eastern Europe Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.3.2 Western Europe
11.3.2.1 Trends Analysis
11.3.2.2 Western Europe Alopecia Treatment Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
11.3.2.3 Western Europe Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.3.2.4 Western Europe Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.3.2.5 Western Europe Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.3.2.6 Western Europe Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.3.2.7 Germany
11.3.2.7.1 Germany Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.3.2.7.2 Germany Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.3.2.7.3 Germany Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.3.2.7.4 Germany Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.3.2.8 France
11.3.2.8.1 France Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.3.2.8.2 France Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.3.2.8.3 France Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.3.2.8.4 France Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.3.2.9 UK
11.3.2.9.1 UK Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.3.2.9.2 UK Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.3.2.9.3 UK Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.3.2.9.4 UK Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.3.2.10 Italy
11.3.2.10.1 Italy Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.3.2.10.2 Italy Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.3.2.10.3 Italy Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.3.2.10.4 Italy Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.3.2.11 Spain
11.3.2.11.1 Spain Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.3.2.11.2 Spain Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.3.2.11.3 Spain Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.3.2.11.4 Spain Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.3.2.12 Netherlands
11.3.2.12.1 Netherlands Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.3.2.12.2 Netherlands Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.3.2.12.3 Netherlands Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.3.2.12.4 Netherlands Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.3.2.13 Switzerland
11.3.2.13.1 Switzerland Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.3.2.13.2 Switzerland Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.3.2.13.3 Switzerland Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.3.2.13.4 Switzerland Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.3.2.14 Austria
11.3.2.14.1 Austria Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.3.2.14.2 Austria Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.3.2.14.3 Austria Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.3.2.14.4 Austria Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.3.2.15 Rest of Western Europe
11.3.2.15.1 Rest of Western Europe Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.3.2.15.2 Rest of Western Europe Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.3.2.15.3 Rest of Western Europe Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.3.2.15.4 Rest of Western Europe Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.4 Asia Pacific
11.4.1 Trends Analysis
11.4.2 Asia Pacific Alopecia Treatment Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
11.4.3 Asia Pacific Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.4.4 Asia Pacific Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.4.5 Asia Pacific Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.4.6 Asia Pacific Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.4.7 China
11.4.7.1 China Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.4.7.2 China Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.4.7.3 China Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.4.7.4 China Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.4.8 India
11.4.8.1 India Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.4.8.2 India Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.4.8.3 India Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.4.8.4 India Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.4.9 Japan
11.4.9.1 Japan Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.4.9.2 Japan Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.4.9.3 Japan Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.4.9.4 Japan Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.4.10 South Korea
11.4.10.1 South Korea Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.4.10.2 South Korea Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.4.10.3 South Korea Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.4.10.4 South Korea Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.4.11 Vietnam
11.4.11.1 Vietnam Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.4.11.2 Vietnam Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.4.11.3 Vietnam Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.4.11.4 Vietnam Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.4.12 Singapore
11.4.12.1 Singapore Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.4.12.2 Singapore Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.4.12.3 Singapore Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.4.12.4 Singapore Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.4.13 Australia
11.4.13.1 Australia Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.4.13.2 Australia Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.4.13.3 Australia Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.4.13.4 Australia Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.4.14 Rest of Asia Pacific
11.4.14.1 Rest of Asia Pacific Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.4.14.2 Rest of Asia Pacific Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.4.14.3 Rest of Asia Pacific Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.4.14.4 Rest of Asia Pacific Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.5 Middle East and Africa
11.5.1 Middle East
11.5.1.1 Trends Analysis
11.5.1.2 Middle East Alopecia Treatment Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
11.5.1.3 Middle East Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.5.1.4 Middle East Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.5.1.5 Middle East Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.5.1.6 Middle East Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.5.1.7 UAE
11.5.1.7.1 UAE Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.5.1.7.2 UAE Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.5.1.7.3 UAE Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.5.1.7.4 UAE Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.5.1.8 Egypt
11.5.1.8.1 Egypt Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.5.1.8.2 Egypt Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.5.1.8.3 Egypt Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.5.1.8.4 Egypt Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.5.1.9 Saudi Arabia
11.5.1.9.1 Saudi Arabia Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.5.1.9.2 Saudi Arabia Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.5.1.9.3 Saudi Arabia Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.5.1.9.4 Saudi Arabia Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.5.1.10 Qatar
11.5.1.10.1 Qatar Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.5.1.10.2 Qatar Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.5.1.10.3 Qatar Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.5.1.10.4 Qatar Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.5.1.11 Rest of Middle East
11.5.1.11.1 Rest of Middle East Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.5.1.11.2 Rest of Middle East Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.5.1.11.3 Rest of Middle East Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.5.1.11.4 Rest of Middle East Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.5.2 Africa
11.5.2.1 Trends Analysis
11.5.2.2 Africa Alopecia Treatment Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
11.5.2.3 Africa Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.5.2.4 Africa Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.5.2.5 Africa Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.5.2.6 Africa Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.5.2.7 South Africa
11.5.2.7.1 South Africa Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.5.2.7.2 South Africa Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.5.2.7.3 South Africa Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.5.2.7.4 South Africa Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.5.2.8 Nigeria
11.5.2.8.1 Nigeria Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.5.2.8.2 Nigeria Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.5.2.8.3 Nigeria Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.5.2.8.4 Nigeria Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.5.2.9 Rest of Africa
11.5.2.9.1 Rest of Africa Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.5.2.9.2 Rest of Africa Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.5.2.9.3 Rest of Africa Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.5.2.9.4 Rest of Africa Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.6 Latin America
11.6.1 Trends Analysis
11.6.2 Latin America Alopecia Treatment Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
11.6.3 Latin America Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.6.4 Latin America Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.6.5 Latin America Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.6.6 Latin America Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.6.7 Brazil
11.6.7.1 Brazil Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.6.7.2 Brazil Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.6.7.3 Brazil Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.6.7.4 Brazil Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.6.8 Argentina
11.6.8.1 Argentina Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.6.8.2 Argentina Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.6.8.3 Argentina Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.6.8.4 Argentina Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.6.9 Colombia
11.6.9.1 Colombia Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.6.9.2 Colombia Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.6.9.3 Colombia Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.6.9.4 Colombia Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.6.10 Rest of Latin America
11.6.10.1 Rest of Latin America Alopecia Treatment Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11.6.10.2 Rest of Latin America Alopecia Treatment Market Estimates and Forecasts, by Gender Type (2020-2032) (USD Billion)
11.6.10.3 Rest of Latin America Alopecia Treatment Market Estimates and Forecasts, by Age Group (2020-2032) (USD Billion)
11.6.10.4 Rest of Latin America Alopecia Treatment Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
12. Company Profiles
12.1 Sun Pharmaceutical Industries Ltd.
12.1.1 Company Overview
12.1.2 Financial
12.1.3 Products/ Services Offered
12.1.4 SWOT Analysis
12.2 Follicum AB
12.2.1 Company Overview
12.2.2 Financial
12.2.3 Products/ Services Offered
12.2.4 SWOT Analysis
12.3 GlaxoSmithKline plc.
12.3.1 Company Overview
12.3.2 Financial
12.3.3 Products/ Services Offered
12.3.4 SWOT Analysis
12.4 Daiichi Sankyo
12.4.1 Company Overview
12.4.2 Financial
12.4.3 Products/ Services Offered
12.4.4 SWOT Analysis
12.5 Fagron
12.5.1 Company Overview
12.5.2 Financial
12.5.3 Products/ Services Offered
12.5.4 SWOT Analysis
12.6 Concert Pharmaceuticals Inc.
12.6.1 Company Overview
12.6.2 Financial
12.6.3 Products/ Services Offered
12.6.4 SWOT Analysis
12.7 Johnson & Johnson
12.7.1 Company Overview
12.7.2 Financial
12.7.3 Products/ Services Offered
12.7.4 SWOT Analysis
12.8 Cipla Inc.
12.8.1 Company Overview
12.8.2 Financial
12.8.3 Products/ Services Offered
12.8.4 SWOT Analysis
12.9 Aclaris Therapeutics, Inc.
12.9.1 Company Overview
12.9.2 Financial
12.9.3 Products/ Services Offered
12.9.4 SWOT Analysis
12.10 Merck & Co., Inc.
12.10.1 Company Overview
12.10.2 Financial
12.10.3 Products/ Services Offered
12.10.4 SWOT Analysis
13. Use Cases and Best Practices
14. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments
By Route of Administration
Topical
Injectable
Oral
By Gender Type
Male
Female
By Age Group
Below 18 years
18 - 34 Years
35 - 49 Years
Above 50 Years
By End User
Hospitals and Physicians offices
Dermatology Clinics
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of the product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The E-Pharmacy Market size was estimated at USD 73.38 billion in 2023 and is expected to reach USD 321.89 billion by 2031 with a growing CAGR of 20.3% during the forecast period of 2024-2031.
The Oral Care Market Size was valued at USD 37.42 billion in 2023 and is expected to reach USD 67.05 billion by 2032, growing at a CAGR of 6.72% over the forecast period 2024-2032.
The Bariatric Surgery Market size was valued at USD 1.70 Bn in 2023 and is expected to reach USD 3.34 Bn by 2032 and grow at a CAGR of 7.85% by 2024-2032.
The Needle-Free Injector Market was valued at USD 15.6 Bn in 2023 and is expected to reach USD 43.4 Bn by 2032 with a growing CAGR of 12.08% from 2024 to 2032.
The Portable Medical Devices Market Size was USD 63.56 Billion in 2023 and will reach USD 158.22 Billion by 2032 and grow at a CAGR of 10.70% by 2024-2032.
The Anesthesia Drugs Market Size was valued at USD 5.9 billion in 2023 & is expected to reach USD 8.6 billion by 2032 with a growing CAGR of 4.2% over the forecast period of 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
